Skip to content

Immunodeficiency 91 And Hyperinflammation C5562073

Published: July 22, 2026Updated: August 25, 2026

A rare disorder where immune deficiency combines with excessive inflammatory responses. It affects children and adults, requiring careful treatment to balance immune function and control inflammation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe headache

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Recurrent fever

(immunologic)

Skin rash

(immunologic)

Hepatomegaly

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunomodulatory Therapy

Targeted immunomodulatory agents to control hyperinflammatory responses while preserving essential immune function against pathogens. Treatment carefully balances inflammatory and infectious risks.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Anti-inflammatory Management

Aggressive anti-inflammatory treatment to control hyperinflammatory manifestations and prevent end-organ damage. Often requires combination approaches for severe cases.

medication

Additional treatment options

Inflammatory Marker Surveillance

Regular monitoring of inflammatory markers including CRP, ESR, and cytokine levels to guide treatment intensity and detect disease flares early.

monitoring

Immunoglobulin Replacement

Immunoglobulin therapy providing immune support while potentially modulating inflammatory responses through immune regulation.

medication

Stress Reduction and Sleep Optimization

Lifestyle modifications emphasizing stress management and adequate sleep, as physiological stress can exacerbate hyperinflammatory states.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Immunodeficiency 91 And Hyperinflammation C5562073?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Immunodeficiency 91 And Hyperinflammation C5562073. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy